Despite the clear evidence of involvement of FGFR2 in breast cancer, and association of polymorphisms in FGFR2 with breast cancer [5,6], the mechanism by which these polymorphisms predispose to breast cancer remains uncertain. This evidence concerns the gene FGFR2 and breast cancer.